Dear all,
I have a database from which the following variables are of interest for my analysis:
id (patient id), time (with the following possible values 1 2 3 6 9 12 - representing the months we investigated particular biomarkers), csa_tac (the medication that was administered during the initial 12 months - csa or tac, binary), CKD_L (a biomarker that was measuread at 1, 2, 3, 6, 9 and 12 months) PU_L (another biomarker that was measured at that particular moments), C0 (the levels of the csa drug), T0 (the levels of the tac drug), location (where the patients was investigated, binary),diabetes (the presence of diabetes, binary, 0 - no, 1 - yes) outcome_30 (the outcome of interest, binary, 0 - no, 1 - yes)
I have the following research questions.
1. Does the CKL_L measurements influence the outcome?
2. Does the effect of CKD_L on the outcome is influenced by the location, the presence of diabetes or by PU_L?
3. Does the level of the medication (csa or tac) influences the CKD_L (I suppose that I have to do this analysis separately for the csa and tac) - and what level could be associated with deleterious effects on the outcome?
I have read different things (even took an online course) about multilevel modelling, but I still don't know how to perform this analyses.
Thank you
I have a database from which the following variables are of interest for my analysis:
id (patient id), time (with the following possible values 1 2 3 6 9 12 - representing the months we investigated particular biomarkers), csa_tac (the medication that was administered during the initial 12 months - csa or tac, binary), CKD_L (a biomarker that was measuread at 1, 2, 3, 6, 9 and 12 months) PU_L (another biomarker that was measured at that particular moments), C0 (the levels of the csa drug), T0 (the levels of the tac drug), location (where the patients was investigated, binary),diabetes (the presence of diabetes, binary, 0 - no, 1 - yes) outcome_30 (the outcome of interest, binary, 0 - no, 1 - yes)
Code:
id time csa_tac CKD_L PU_L CO_L T0_L location diabetes outcome_30 1 1 1 64 0 210 . 2 0 0 1 2 1 52 0 244 . 2 0 0 1 3 1 32 .9 . . 2 0 0 1 6 1 44 0 . . 2 0 0 1 9 1 63 0 . . 2 0 0 1 12 1 63 0 . . 2 0 0 2 1 1 54 .3 236 . 1 0 0 2 2 1 58 0 . . 1 0 0 2 3 1 58 0 . . 1 0 0 2 6 1 34 0 . . 1 0 0
I have the following research questions.
1. Does the CKL_L measurements influence the outcome?
2. Does the effect of CKD_L on the outcome is influenced by the location, the presence of diabetes or by PU_L?
3. Does the level of the medication (csa or tac) influences the CKD_L (I suppose that I have to do this analysis separately for the csa and tac) - and what level could be associated with deleterious effects on the outcome?
I have read different things (even took an online course) about multilevel modelling, but I still don't know how to perform this analyses.
Thank you
Comment